Last quarter (Q4 2023), Ocular Therapeutix's total revenue was $14.80M, an increase of 5.16% from the same quarter last year. In Q4, Ocular Therapeutix's net income was $-29.22M. See Ocular Therapeutix’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 58.44M	$ 58.44M	$ 51.49M	$ 43.52M	$ 17.40M	$ 4.23M
Cost of Revenue	$ 5.28M	$ 5.28M	$ 4.54M	$ -4.41M	$ 2.08M	$ 2.33M
Gross Profit	$ 53.16M	$ 53.16M	$ 46.95M	$ 39.12M	$ 15.32M	$ 1.90M
Operating Expense	$ 135.54M	$ 135.54M	$ 125.61M	$ 117.15M	$ 78.17M	$ 87.70M
Operating Income	$ -82.38M	$ -82.38M	$ -78.65M	$ -78.04M	$ -62.85M	$ -85.80M
Net Non Operating Interest Income Expense	$ -8.90M	$ -11.34M	$ -7.02M	$ 71.48M	$ -6.60M	$ -4.87M
Other Income Expense	$ -10.54M	$ -12.98M	$ -14.64M	$ -1.00K	$ -86.19M	$ 4.30M
Pretax Income	$ -80.74M	$ -80.74M	$ -71.04M	$ -6.55M	$ -155.64M	$ -86.37M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -80.74M	$ -80.74M	$ -71.04M	$ -6.55M	$ -155.64M	$ -86.37M
Basic EPS	$ -1.01	$ -1.01	$ -0.92	$ -0.09	$ -2.56	$ -1.91
Diluted EPS	$ -1.19	$ -1.02	$ -0.97	$ -0.98	$ -2.56	$ -1.91
Basic Average Shares	$ 319.31M	$ 79.83M	$ 76.88M	$ 76.39M	$ 60.75M	$ 45.27M
Diluted Average Shares	$ 342.39M	$ 85.60M	$ 82.64M	$ 82.16M	$ 60.75M	$ 45.27M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 140.82M	$ 140.82M	$ 130.15M	$ 112.75M	$ 80.25M	$ 90.03M
Net Income From Continuing And Discontinued Operation	$ -80.74M	$ -80.74M	$ -71.04M	$ -6.55M	$ -155.64M	$ -86.37M
Normalized Income	$ -39.83M	$ -63.78M	$ -56.12M	-	$ -69.45M	$ -90.68M
Interest Expense	-	-	-	-	$ 6.77M	$ 6.10M
EBIT	$ -69.40M	$ -69.40M	$ -64.02M	$ 118.00K	$ -148.87M	$ -80.27M
EBITDA	$ -66.18M	$ -60.31M	$ -57.05M	$ 7.17M	$ -146.09M	$ -77.74M

Currency in USD

Ocular Therapeutix Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing